Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2018 Apr 1;77(4):358–364. doi: 10.1097/QAI.0000000000001604

Table 3.

Effects of PrEP Use and Adherence on Condomless Anal Sex in HIV-Negative Seroconcordant Partnerships

Outcome Predictor IRR Confidence Interval (95%) p-value
Insertive sex Participant on PrEP 0.89 0.68 – 1.16 0.388
Non-Adherent 1.03 0.71 – 1.52 0.864
Adherent 0.8 0.57 – 1.11 0.175

Insertive CAS Participant on PrEP 1.16 0.79 – 1.71 0.451
Non-Adherent 1.53 0.89 – 2.63 0.122
Adherent 0.94 0.59 – 1.51 0.807

Receptive sex Participant on PrEP 1.27 1 – 1.61 0.049
Non-Adherent 1.33 0.95 – 1.88 0.101
Adherent 1.24 0.94 – 1.62 0.129

Receptive CAS Participant on PrEP 1.49 1.05 – 2.12 0.025
Non-Adherent 1.79 1.09 – 2.93 0.021
Adherent 1.33 0.88 – 2.01 0.177

Total anal sex Participant on PrEP 1.07 0.9 – 1.28 0.441
Non-Adherent 1.12 0.86 – 1.45 0.392
Adherent 1.04 0.85 – 1.29 0.683

Total CAS Participant on PrEP 1.32 1 – 1.76 0.052
Non-Adherent 1.62 1.09 – 2.42 0.018
Adherent 1.16 0.83 – 1.62 0.399

NOTE: HIV-negative seroconcordant refers to partnerships in which the participant is HIV-negative and the partner is perceived HIV-negative/unknown. PrEP = pre-exposure prophylaxis; IRR = incidence-rate ratio; CAS = condomless anal sex.